Finance

Beta
Lists
605033:SHA
Shaanxi Meibang Pharmaceuticl Grp Co Ltd
CN¥16.05
-0.93%
(-0.15) 1D
Jul 22, 2:11:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605033...
Open
CN¥16.20
High
CN¥16.48
Low
CN¥16.02
Mkt. cap
2.25B
Avg. vol.
1.87M
Volume
1.52M
Dividend
0.93%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 17, 2026
P/E ratio
39.94
52-wk high
CN¥34.69
52-wk low
CN¥15.81
EPS
CN¥0.40
No. of employees
1K
Open
CN¥16.20
High
CN¥16.48
Low
CN¥16.02
Mkt. cap
2.25B
Avg. vol.
1.87M
Volume
1.52M
Dividend
0.93%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 17, 2026
P/E ratio
39.94
52-wk high
CN¥34.69
52-wk low
CN¥15.81
EPS
CN¥0.40
No. of employees
1K
News stories
From sources across the web
About Shaanxi Meibang Pharmaceuticl Grp Co Ltd
CEO-
Employees1.12K
FoundedAug 5, 1998
Headquarters-
SectorFertilizer
Websitemeibang.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
195.92M
123.56M
303.07M
336.34M
Cost of goods sold
134.27M
79.06M
213.68M
212.57M
Cost of revenue
134.27M
79.06M
213.68M
212.57M
Research and development expenses
21.16M
20.44M
22.88M
20.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.21M
31.99M
55.73M
49.16M
Operating expense
59.99M
44.93M
77.94M
78.96M
Total operating expenses
194.27M
123.98M
291.63M
291.53M
Operating income
1.65M
-426.70K
11.44M
44.81M
Other non operating income
-1.16M
1.27M
-1.41M
248.76K
EBT including unusual items
5.98M
-786.23K
16.07M
44.95M
EBT excluding unusual items
2.33M
2.49M
12.36M
46.26M
Income tax expense
-209.76K
-845.03K
3.60M
9.33M
Effective tax rate
-3.51%
107.48%
22.42%
20.75%
Other operating expenses
-349.35K
-164.41K
2.54M
1.12M
Net income
6.18M
58.80K
12.47M
35.62M
Net profit margin
3.16%
0.05%
4.11%
10.59%
Earnings per share
-
-
-
-
Interest and investment income
1.83M
1.69M
2.69M
1.45M
Interest expense
-
-28.67K
-367.68K
-247.12K
Net interest expenses
1.83M
1.66M
2.32M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.35M
4.68M
19.24M
52.61M
Gain or loss from assets sale
42.87K
-42.87K
-187.58K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer